Understanding reproductive health among women with disabilities, immigrant and refugee populations, and cancer survivors—and why accessible healthcare, medical coordination, fertility preservation, and informed reproductive choice matter before pregnancy.
What does it mean to prepare for pregnancy when healthcare is not equally accessible to everyone?
For some women, preconception planning begins with a discussion about nutrition, reproductive hormones, or prenatal vitamins.
For others, the process is more complicated.
A woman living with a neurological or physical disability may need to understand how pregnancy could affect her functional abilities or existing medical conditions.
A refugee rebuilding her life in a new country may face language barriers, unfamiliar healthcare systems, or difficulties obtaining continuous medical care.
A cancer survivor may have unanswered questions about whether previous treatment affected her fertility, whether pregnancy is medically safe, or how to balance reproductive goals with ongoing cancer therapy.
These circumstances are different, yet they share an important principle.
Meaningful preconception care must recognize the individual's medical circumstances, lived experiences, available resources, and reproductive goals.
In 2008, Catherine Ruhl and Barbara Moran published The Clinical Content of Preconception Care: Preconception Care for Special Populations in the American Journal of Obstetrics & Gynecology.
The authors focused on three groups: women with disabilities, immigrant and refugee women, and cancer survivors.
They argued that effective preconception care should pursue three goals: reduce preventable health risks, promote long-term well-being, and support informed reproductive planning.
They also recognized that medical conditions are only part of the challenge.
Physical accessibility, communication, cultural understanding, financial resources, psychological support, and healthcare coordination can all influence whether a woman receives meaningful care.
Nearly two decades later, contemporary research has expanded our understanding of these issues.
Advances in fertility preservation have created new reproductive opportunities for cancer survivors.
Large population studies have identified important differences in pregnancy outcomes among women with disabilities.
And research involving refugee populations has clarified how language access, trust, and healthcare-system barriers influence the patient experience.
Yet one of the original paper's most important observations remains relevant today.
Healthcare professionals must not assume that a woman does not wish to become pregnant simply because she has a disability, complex medical history, or challenging social circumstances.
The goal is not to decide which patients should pursue pregnancy.
It is to help individuals understand their options, navigate relevant health considerations, and make informed decisions.
1. What Is Individualized Preconception Care?
Preconception care involves identifying and addressing health-related factors that may influence conception, pregnancy, and future well-being.
For women with complex health needs, this process may require more than standard preventive recommendations.
An individual may need medication review, specialist evaluation, fertility counseling, accessibility accommodations, or assistance navigating healthcare services.
However, individualized care should not be confused with simply performing more tests.
The objective is to identify what matters for a particular person.
A woman with stable multiple sclerosis may require different preparation from someone with a spinal cord injury.
A woman previously treated with chemotherapy may require different reproductive counseling from someone receiving active cancer treatment.
An immigrant who has reliable healthcare access and no significant medical concerns may need little additional investigation.
The most useful preconception approach is therefore based on a person's actual circumstances rather than broad demographic labels.
2. Disability and Pregnancy: Challenging Assumptions
One of the central arguments in the 2008 AJOG paper was that women with disabilities can have healthy pregnancies.
Disability does not automatically imply infertility.
Nor does it establish that pregnancy is medically contraindicated.
However, the original authors also described barriers that women with disabilities may encounter when seeking reproductive healthcare.
These included inaccessible facilities, inadequate accommodations, and clinicians assuming that disabled women were not sexually active or interested in becoming parents.
Such assumptions can prevent individuals from receiving relevant preventive care.
For example, a patient who is never asked about reproductive intentions may miss opportunities for preconception counseling.
A woman who cannot access an examination table may experience delays in routine gynecological care.
Someone with communication needs may not receive information in an accessible format.
The problem is not necessarily the disability itself.
In some circumstances, healthcare systems create avoidable barriers that compound an individual's medical needs.
3. What Does Modern Research Reveal About Pregnancy Outcomes in Women With Disabilities?
In March 2025, researchers published Identifying Pregnant Women With Disabilities and Maternal and Newborn Outcomes in JAMA Network Open.
The retrospective cohort study examined 921,218 live births within Texas Medicaid data.
Researchers investigated different approaches to identifying women with disabilities.
Some individuals were identified through disability-associated diagnostic codes.
Others were identified through enrollment in disability-related benefits programs.
A smaller group met both definitions.
The study revealed an important methodological problem.
These approaches identified substantially different groups of women, with relatively little overlap.
The rates of adverse pregnancy outcomes also varied.
For example, preterm birth occurred in approximately 10.4% of births among women without an identified disability, compared with 18.3% among women identified through diagnostic codes alone.
Differences were also observed in low birth weight, severe maternal morbidity, and other outcomes.
However, these findings require careful interpretation.
The study was observational and evaluated historical administrative data.
It did not establish that disability itself caused the observed complications.
The groups also differed in medical conditions and other characteristics.
Most importantly, disability encompasses many distinct conditions with different physiological implications.
A woman with a sensory disability does not necessarily have the same obstetric risks as someone with a progressive neurological disorder.
The study therefore supports better identification, research, and individualized care—not the assumption that every disabled woman has a high-risk pregnancy.
4. Disability Is Not a Single Biological Category
The term disability describes a broad range of functional limitations and circumstances.
These may involve mobility, sensation, cognition, communication, or other aspects of functioning.
Some disabilities arise from conditions affecting neurological or musculoskeletal systems.
Others involve sensory impairments or developmental conditions.
Certain disabilities are stable.
Others fluctuate or progress over time.
Some have relatively little direct influence on pregnancy physiology.
Others may interact with cardiovascular, respiratory, autonomic, or other systems affected by gestation.
Consequently, preconception assessment should begin by understanding the specific condition.
Relevant questions include whether the condition is stable, which physiological systems are affected, what medications are being used, and which functional activities may become more challenging during pregnancy.
The objective is to identify meaningful interactions between the patient's health and the physiological demands of pregnancy.
5. Why Functional Capacity Matters During Pregnancy
Pregnancy involves substantial physiological adaptation.
Blood volume and cardiac output increase.
Respiratory mechanics change.
Body mass distribution and postural demands evolve.
Connective tissues and musculoskeletal loading are affected.
For women with existing limitations in mobility, balance, strength, or endurance, these changes may create additional challenges.
For example, someone with impaired balance may require strategies to reduce fall risk.
A wheelchair user may need assistance reviewing mobility equipment, seating, skin protection, and positioning.
A person with respiratory muscle weakness may require pulmonary evaluation.
Someone with significant spasticity or chronic pain may need a carefully coordinated treatment plan.
However, a functional limitation should not automatically be treated as a reason to avoid physical activity.
When appropriate, rehabilitation and adapted exercise can support physical capacity, independence, and quality of life.
The appropriate program depends on the underlying condition and pregnancy-related considerations.
6. Neurological Conditions and Reproductive Planning
Several neurological conditions may warrant specialized preconception assessment.
Examples include multiple sclerosis, epilepsy, spinal cord injury, certain neuromuscular disorders, and neurological conditions affecting autonomic regulation.
Each presents different considerations.
For women with epilepsy, medication review and seizure management are important because some antiseizure medications carry fetal risks, while uncontrolled seizures can also be dangerous.
For women with multiple sclerosis, pregnancy planning may involve reviewing disease activity and disease-modifying therapies.
For individuals with spinal cord injury, assessment may address bladder and bowel function, skin integrity, mobility, and autonomic dysreflexia.
Autonomic dysreflexia is particularly important in some individuals with spinal cord injuries at or above the T6 neurological level.
It can produce potentially dangerous elevations in blood pressure in response to stimuli below the injury level.
Labor, bladder distention, and other triggers may require specialized obstetric and anesthetic planning.
These examples demonstrate why neurological preconception assessment should be condition-specific.
They also show the importance of coordinated care among the patient's existing specialists and maternal-fetal medicine professionals.
7. Dysautonomia, Orthostatic Intolerance, and Pregnancy
Autonomic nervous system disorders can influence heart rate, vascular regulation, blood pressure, temperature control, and other physiological functions.
For individuals with postural orthostatic tachycardia syndrome or other forms of orthostatic intolerance, pregnancy may affect symptoms because of changes in circulating blood volume and cardiovascular physiology.
Some patients experience improvement during portions of pregnancy.
Others experience symptom exacerbation.
The available research remains limited, and responses vary.
Preconception planning may involve reviewing symptoms, medications, hydration strategies, activity tolerance, and relevant comorbidities.
However, recommendations must account for the patient's diagnosis and pregnancy status.
Not every intervention used outside pregnancy is appropriate during gestation.
A coordinated plan involving obstetric and autonomic specialists may be valuable when symptoms are significant.
The objective is to support physiological stability and functional capacity without assuming that all autonomic disorders carry the same reproductive risks.
8. Autoimmune and Inflammatory Conditions
Some women with complex health needs have autoimmune or inflammatory disorders requiring ongoing treatment.
Examples include systemic lupus erythematosus and rheumatoid arthritis.
These conditions can influence pregnancy in different ways.
Systemic lupus erythematosus may increase the risk of certain complications, particularly when disease activity is elevated or specific organ systems are affected.
Autoantibody status, kidney involvement, and other clinical characteristics may influence management.
Certain medications used to control autoimmune disease are compatible with pregnancy.
Others require adjustment before conception.
Importantly, discontinuing effective treatment without medical supervision can result in disease exacerbation.
Pregnancy planning should therefore balance disease control with medication safety.
For some conditions, achieving sustained clinical stability before conception can be an important objective.
However, treatment decisions belong with the patient's rheumatology and obstetric teams.
9. Medication Safety: Why Coordination Matters
Women with disabilities or chronic health conditions may use medications that require review before pregnancy.
Examples include certain antiseizure medications, immunomodulatory treatments, anticoagulants, or drugs used for pain and spasticity.
The purpose of medication review is not to eliminate every prescription.
It is to assess the benefits of treating the underlying condition alongside potential reproductive or developmental risks.
In some circumstances, an alternative medication may be appropriate.
In others, maintaining treatment is safer than allowing the underlying disease to become uncontrolled.
Medication changes may also require time.
For example, some therapies must be discontinued well before conception, while others require gradual adjustment.
These decisions should be managed by qualified prescribing clinicians.
A preconception consultation creates an opportunity for planning rather than responding to medication questions only after pregnancy begins.
10. Accessible Healthcare Is Part of Clinical Quality
Healthcare accessibility is sometimes treated as an administrative issue rather than a clinical one.
But accessibility can directly affect the quality and timeliness of care.
Relevant accommodations may include accessible examination tables, wheelchair-compatible scales, appropriately designed restrooms, and assistance with safe transfers.
Other patients may require communication accommodations, including sign-language interpretation, accessible written materials, or additional time for appointments.
Clinicians should ask patients what accommodations they prefer rather than make assumptions.
An individual who uses a wheelchair may not need the same assistance as another wheelchair user.
A person with a hearing impairment may prefer a particular communication format.
Respectful, individualized accommodation supports informed consent and reduces unnecessary barriers.
It is also important to distinguish physical accessibility from broader functional participation.
Access means more than entering a building.
It means being able to receive appropriate examinations, communicate with clinicians, and participate meaningfully in healthcare decisions.
11. Reproductive Autonomy and Disability
One of the most important ethical considerations in preconception care is reproductive autonomy.
Women with disabilities have the same fundamental interest in making informed decisions about pregnancy and parenthood as other patients.
Healthcare professionals should avoid assumptions about whether a person wants children.
They should also avoid treating disability as an automatic indication for contraception or pregnancy avoidance.
When a patient has cognitive or communication differences, care should emphasize appropriate supported decision-making and informed consent.
Support needs should not be confused with an absence of personal preferences.
Genetic counseling may be useful when an inherited condition is involved.
However, the purpose of counseling is to explain potential risks and reproductive options rather than direct the patient toward a predetermined choice.
12. Immigrant and Refugee Women: Why Context Matters
The second population examined in the original AJOG paper was immigrant and refugee women.
These groups are not interchangeable.
Immigration may occur for education, employment, family reunification, or numerous other reasons.
Refugee experiences often involve forced displacement related to persecution, violence, or conflict.
Even within these groups, medical and social circumstances vary considerably.
Some individuals arrive with strong social support, good health, and established resources.
Others experience major disruptions in healthcare access.
The original paper discussed barriers involving language, insurance, cultural differences, and previous exposure to adversity.
These remain relevant.
However, immigrant status should not be treated as a medical diagnosis or a reliable predictor of health.
The appropriate approach is to understand the individual's actual history and circumstances.
13. What Does Recent JAMA Research Reveal About Refugee Healthcare?
A 2026 qualitative study published in JAMA Network Open, Health and Health Care Access Among Afghan Refugee Women in the United States, explored experiences of Afghan women receiving healthcare after resettlement.
Researchers interviewed 23 women living in the San Francisco Bay Area.
Participants described several barriers, including inadequate interpretation services, cultural misunderstandings, limited reproductive health education, and difficulties navigating healthcare systems.
Some women reported experiences in which communication problems or insufficient informed consent contributed to mistrust.
Others described challenges involving family expectations, psychological distress, and unfamiliar healthcare processes.
The study also identified structural issues such as long appointment waits and limited access to suitable services.
These findings help illustrate why simply making an appointment available may not be sufficient.
However, this was a small qualitative study involving one population and geographic area.
Its findings should not be generalized to every Afghan refugee or all immigrant women.
The value lies in identifying patient experiences that healthcare systems should take seriously.
14. Language Access Is a Patient-Safety Issue
Effective healthcare depends on accurate communication.
Preconception counseling often involves complex discussions about medications, genetic risks, screening, reproductive goals, and treatment options.
Misunderstanding this information can have meaningful consequences.
Professional medical interpretation can help patients understand recommendations and communicate concerns accurately.
Relying exclusively on family members for interpretation may introduce problems involving privacy, accuracy, or patient autonomy.
This is particularly important when discussing sensitive topics such as reproductive intentions, intimate partner violence, or mental health.
Written materials should also be provided in an accessible language and format when feasible.
The goal is not simply translation.
It is ensuring that the patient understands the information and can participate in decisions.
15. Culturally Responsive Care Without Stereotyping
Culture can influence how people understand illness, family planning, treatment, and interactions with healthcare professionals.
However, cultural background should not be used to make assumptions about an individual.
Two people from the same country may have very different beliefs, educational experiences, or healthcare preferences.
A culturally responsive approach begins with curiosity rather than stereotyping.
Clinicians can ask how the patient understands a medical concern, whether traditional practices are important to them, and whether any healthcare recommendations conflict with personal values.
The objective is collaborative care.
A patient may wish to incorporate familiar foods or cultural dietary practices into preconception nutrition planning.
Another may have questions about particular medications or medical procedures.
By creating space for discussion, healthcare professionals can improve understanding without treating cultural differences as deficiencies.
16. Refugee Health: Infectious Disease Screening and Immunization
Some refugees arrive from regions with different infectious disease prevalence or vaccination schedules.
Relevant considerations may include hepatitis B, tuberculosis, parasitic infections, and other conditions.
However, screening should be based on medical history, geographic exposure, previous testing, and established public health recommendations.
It should not be determined solely by immigrant status.
Preconception care may provide an opportunity to review immunization records and identify needed vaccinations.
For example, rubella and varicella immunity can be particularly important before pregnancy.
Some vaccines require administration before conception.
Other vaccines may be given during pregnancy when indicated.
Patients who have already completed recommended refugee health screening may not require repeated testing unless new risks or clinical indications exist.
The goal is continuity of appropriate preventive care.
17. Trauma, Stress, and Reproductive Health
Forced displacement and migration can involve major psychological and social stressors.
For some individuals, these include exposure to violence, loss of loved ones, separation from family, or prolonged uncertainty.
Resettlement may introduce additional challenges involving housing, employment, language, and access to healthcare.
However, not every refugee has experienced the same events or psychological consequences.
Trauma-informed care should avoid assuming that someone has a psychiatric disorder because of their migration history.
Instead, clinicians should establish trust, explain procedures, respect privacy, and provide opportunities for patients to discuss concerns voluntarily.
When psychological symptoms are present, appropriate mental health support may be beneficial.
Preconception counseling can also address practical issues such as financial security, food access, and social support.
These considerations are relevant because reproductive health takes place within everyday life rather than in isolation from social circumstances.
18. The Healthy Migrant Effect: Why Population Statistics Require Caution
The original AJOG paper discussed what is sometimes called the healthy migrant effect.
This refers to observations that certain immigrant populations have favorable health outcomes compared with some groups in their receiving countries.
Several explanations have been proposed, including differences in pre-migration health, selection processes, social support, and health behaviors.
However, results vary according to country of origin, migration circumstances, time since migration, and the outcomes measured.
It would be inappropriate to assume that all immigrants have better or worse pregnancy outcomes than U.S.-born women.
Similarly, population-level findings cannot determine an individual's health status.
Preconception care should therefore use epidemiological research to understand possible needs without allowing broad statistical categories to substitute for individual assessment.
19. Cancer Survivorship and Reproductive Health
The third major population examined in the original AJOG paper was cancer survivors.
Advances in diagnosis and treatment have increased survival for many cancers.
As a result, more individuals are living for years or decades after cancer treatment and considering future parenthood.
This creates important opportunities for survivorship care.
However, cancer and its treatment may affect reproductive health in different ways.
Some treatments can reduce fertility.
Others can cause organ-related complications that become relevant during pregnancy.
Certain cancers may involve inherited genetic risk.
Psychological considerations may also influence family-planning decisions.
The appropriate preconception approach depends on the cancer diagnosis, treatment history, current health, and reproductive goals.
20. How Cancer Treatments Can Affect Fertility
Cancer treatment may affect fertility through several mechanisms.
Certain chemotherapy agents can damage developing germ cells or ovarian follicles.
Radiation exposure involving reproductive organs may impair reproductive function.
Some surgical procedures alter reproductive anatomy.
Hormonal therapies may delay the time when pregnancy can safely be attempted.
However, not all treatments have the same effects.
The degree of fertility risk depends on the specific agents, cumulative dose, radiation location, treatment duration, and age at treatment.
For example, some alkylating chemotherapy agents carry substantial gonadotoxic potential.
Pelvic radiation can affect ovarian function and, in certain circumstances, uterine tissues.
By contrast, other cancer treatments may have limited or uncertain long-term reproductive effects.
A detailed treatment history is therefore essential.
A general statement that someone previously received chemotherapy is insufficient to determine their fertility prognosis.
21. Fertility Preservation: A Major Advance Since 2008
One of the most important developments in reproductive medicine is the expansion of fertility-preservation options.
In 2025, the American Society of Clinical Oncology published updated guidance on fertility preservation in people with cancer.
The guideline emphasized discussing potential infertility as early as possible, ideally before cancer-directed treatment begins.
Patients interested in fertility preservation—or uncertain about their future reproductive goals—should be referred promptly to appropriate specialists.
For women, established options include embryo cryopreservation, mature oocyte cryopreservation, and ovarian tissue cryopreservation in suitable circumstances.
Some patients may also be eligible for fertility-preserving surgical approaches.
For men, sperm cryopreservation remains an established option.
These interventions differ in indications, feasibility, effectiveness, and potential risks.
They should be discussed within the context of the individual's cancer treatment and preferences.
22. Egg Freezing, Embryo Freezing, and Ovarian Tissue Preservation
Egg freezing involves retrieving mature oocytes and storing them for possible future use.
Embryo freezing involves fertilizing retrieved oocytes before cryopreservation.
Both are established fertility-preservation options.
However, they differ in practical, personal, and legal considerations.
Embryo cryopreservation requires sperm at the time embryos are created.
Oocyte cryopreservation may provide more flexibility for some individuals.
Ovarian tissue cryopreservation involves collecting and freezing ovarian tissue for possible future transplantation.
Unlike conventional egg retrieval, it does not necessarily require ovarian stimulation.
This can make it particularly relevant when cancer treatment must begin urgently.
It is also an established fertility-preservation method for certain prepubertal patients.
However, transplantation may not be appropriate for every cancer because of concerns about potentially reintroducing malignant cells.
No preservation method guarantees a future pregnancy or live birth.
The decision should involve specialist counseling concerning feasibility, expected outcomes, costs, and individual goals.
23. Can Fertility Preservation Occur After Cancer Treatment?
Historically, fertility preservation was discussed primarily before cancer therapy.
The 2025 ASCO guidance recognizes that certain patients may also benefit from fertility-preservation options after treatment.
This may include individuals who did not undergo preservation before therapy or who wish to preserve additional reproductive potential.
However, treatment may have reduced the number or quality of available oocytes.
The feasibility of post-treatment ovarian stimulation depends on remaining ovarian function and other clinical circumstances.
Measures such as anti-Müllerian hormone and antral follicle count can contribute to assessment.
However, these measurements do not directly predict whether an individual can conceive naturally.
Nor do they provide a complete estimate of future live-birth probability.
Cancer survivors should discuss testing and fertility options with qualified reproductive specialists rather than relying on one laboratory measurement.
24. Pregnancy After Breast Cancer: What Does the NEJM POSITIVE Trial Show?
An especially important development concerns pregnancy after hormone receptor–positive breast cancer.
Some patients receive adjuvant endocrine therapy for several years to reduce the risk of cancer recurrence.
This can create a difficult conflict between treatment duration and reproductive timing.
In 2023, researchers published Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer in The New England Journal of Medicine.
The POSITIVE trial evaluated 516 women aged 42 years or younger who had previously received treatment for hormone receptor–positive early breast cancer.
Participants had completed 18–30 months of adjuvant endocrine therapy before temporarily interrupting treatment to attempt pregnancy.
Among 497 women followed for pregnancy status, 368 experienced at least one pregnancy and 317 had at least one live birth.
At a median follow-up of 41 months, the three-year incidence of breast cancer events was approximately 8.9% in the treatment-interruption group, compared with 9.2% in an external control cohort.
The investigators did not observe an increased short-term risk of breast cancer events in the selected trial population.
These findings provide important information for reproductive counseling.
However, the trial was not a randomized comparison, and longer-term follow-up remains essential.
The results do not mean that endocrine therapy can be safely interrupted by every breast cancer survivor.
Such decisions require individualized oncology management.
25. Why Pregnancy Timing After Cancer Cannot Follow One Universal Rule
The original AJOG paper described a commonly used recommendation to wait approximately two years after breast cancer diagnosis before attempting conception.
Contemporary care has become more individualized.
The appropriate timing depends on cancer type, stage, treatment, recurrence risk, ongoing medications, and reproductive circumstances.
Some individuals may be able to consider pregnancy relatively soon after completing treatment.
Others require longer periods of therapy or surveillance.
The timing may also be influenced by fertility-related considerations.
Age and prior gonadotoxic treatment can affect reproductive potential.
These factors create situations where prolonged delays may have meaningful consequences.
The decision must balance oncological safety with reproductive goals.
No fixed waiting period is appropriate for every cancer survivor.
26. Cancer Survivors and Cardiovascular Health
Cancer survivorship care must consider more than fertility.
Some cancer treatments can affect cardiovascular function.
Anthracycline chemotherapy and radiation involving the chest are particularly relevant.
These exposures may increase the risk of cancer therapy–related cardiac dysfunction.
Pregnancy increases circulating blood volume and cardiac workload.
Consequently, previously unrecognized cardiac impairment may become clinically important.
The 2025 European Society of Cardiology guidelines emphasize individualized cardiovascular assessment and appropriate multidisciplinary care for cancer survivors planning pregnancy.
Patients with previous treatment-related cardiac dysfunction may require evaluation before conception.
Echocardiography and other assessments may be appropriate based on treatment history and current clinical findings.
However, not every cancer survivor requires the same intensity of cardiovascular monitoring.
The goal is risk-based evaluation, not universal classification of cancer survivors as having cardiac disease.
27. What About Pregnancy After Pelvic or Abdominal Radiation?
Radiation affecting the pelvis or abdomen can have implications beyond ovarian function.
Depending on dose and anatomical exposure, treatment may affect uterine tissues, vascular function, or other structures.
Some survivors who received substantial uterine radiation may face increased risks involving fetal growth, preterm delivery, or other obstetric complications.
However, risk varies considerably according to age at exposure, radiation dose, treatment field, and other factors.
A history of pelvic radiation should therefore prompt specialist review when pregnancy is being considered.
Treatment records can provide valuable information.
The objective is to determine whether additional monitoring or reproductive counseling is needed.
28. Hereditary Cancer Syndromes and Reproductive Choices
Certain cancers are associated with inherited pathogenic genetic variants.
Examples include some hereditary breast and ovarian cancer syndromes and Lynch syndrome.
A person carrying a disease-associated variant may wish to understand the possibility of transmitting that variant to a child.
Genetic counseling can help clarify inheritance patterns, penetrance, and potential reproductive implications.
Some individuals may consider assisted reproductive technologies with preimplantation genetic testing for a known familial condition.
Others may prefer natural conception, donor gametes, adoption, or other options.
These choices involve medical, ethical, financial, and personal considerations.
A genetic diagnosis should not be treated as a directive about whether someone should become a parent.
The purpose of counseling is to support informed and voluntary decisions.
29. Psychological Health After Cancer
Cancer can affect psychological well-being long after treatment ends.
Some survivors experience persistent fatigue, cognitive symptoms, anxiety about recurrence, or uncertainty surrounding reproductive health.
Fertility-related concerns may produce additional distress.
A person may grieve changes in reproductive potential even while feeling grateful for successful cancer treatment.
Others may experience pressure from family members or uncertainty about the timing of parenthood.
Preconception care should provide space for these concerns.
When needed, psychological counseling, survivorship support, and fertility counseling can help individuals navigate uncertainty.
However, psychological responses vary.
Cancer survivorship should not automatically be equated with ongoing emotional dysfunction.
The appropriate approach is to ask about the individual's experience and offer support according to their needs.
30. The Importance of Interdisciplinary Care
Women with complex preconception needs may benefit from healthcare teams involving several disciplines.
Depending on the circumstances, this may include obstetrics, maternal-fetal medicine, reproductive endocrinology, oncology, cardiology, neurology, rehabilitation, mental health, nutrition, or other specialties.
However, multidisciplinary care should not simply mean adding more appointments.
Effective collaboration requires communication, clear responsibilities, and shared goals.
For example, a cancer survivor planning pregnancy may need coordination between her oncologist and reproductive endocrinologist.
A woman with spinal cord injury may need input from rehabilitation medicine, anesthesiology, and obstetrics.
A refugee with complex medical needs may benefit from primary care coordination and professional interpretation services.
The goal is to reduce fragmentation while addressing clinically meaningful concerns.
31. A Comprehensive Preconception Assessment for Women With Complex Health Needs
An individualized assessment may consider several domains.
Reproductive goals: Does the individual wish to become pregnant, avoid pregnancy, or explore future family-building options?
Medical history: Which conditions may influence pregnancy or require specialist coordination?
Medications: Are current treatments appropriate for pregnancy planning, and should prescribing clinicians review alternatives?
Functional health: Are there relevant mobility, balance, respiratory, autonomic, or other physiological considerations?
Fertility: Is there a history of cancer treatment, reproductive surgery, or another condition that may affect fertility?
Genetic history: Is counseling indicated because of an inherited condition or familial cancer syndrome?
Psychological well-being: Are there concerns involving trauma, mental health, stress, or reproductive uncertainty?
Accessibility: What physical, communication, or administrative accommodations would improve access to care?
Social circumstances: Are language, transportation, insurance, housing, or food access important barriers?
Care coordination: Which clinicians should participate in developing the preconception plan?
Not every patient requires every component.
The purpose is to identify relevant needs and create a coordinated path forward.
32. How This Research Informs Our Preconception Care
We recognize that reproductive health is influenced by more than biological fertility.
Medical complexity, functional capacity, environmental circumstances, access to healthcare, and individual values can all shape the preconception experience.
Our conscious conception philosophy emphasizes personalized health education, relevant lifestyle assessment, and collaborative care.
For women living with neurological or musculoskeletal conditions, this may involve evaluating movement capacity, physical function, and relevant health behaviors.
For individuals with chronic medical conditions, it may involve identifying appropriate opportunities for nutrition, exercise, sleep, and stress-management support while coordinating with prescribing clinicians.
For cancer survivors, preconception preparation may involve reviewing survivorship concerns and facilitating referrals for fertility, genetic, cardiovascular, or oncological assessment.
For immigrant or refugee patients, effective care may require attention to communication preferences, cultural context, and access to appropriate services.
We also recognize that complex healthcare needs should not automatically result in excessive testing or unnecessarily restrictive recommendations.
A personalized approach should be proportionate to the individual's actual circumstances.
When specialist evaluation, pregnancy risk assessment, fertility preservation, or cancer-related treatment decisions are required, these services belong with appropriately qualified medical professionals.
Our role is to help patients understand relevant health factors, develop sustainable wellness practices, and coordinate supportive care within the appropriate clinical framework.
Importantly, reproductive decisions remain the patient's own.
Our objective is not to define who is an appropriate candidate for parenthood. It is to help individuals understand their health, access appropriate expertise, and pursue informed reproductive decisions.
Conclusion: The Future of Preconception Care Must Be More Inclusive
The original 2008 AJOG article challenged an important limitation of conventional reproductive healthcare.
Women with disabilities, immigrant and refugee women, and cancer survivors may have medical or social circumstances that make pregnancy planning more complex.
However, complexity should not be confused with incapacity.
Modern research has expanded our understanding of both the risks and the opportunities involved.
Large studies have helped identify differences in pregnancy outcomes among women with disabilities.
Research involving refugee populations has clarified barriers related to language, communication, and healthcare access.
Advances in reproductive medicine have expanded fertility-preservation options for cancer survivors.
And contemporary oncology research has provided new evidence to guide selected patients considering pregnancy after breast cancer.
Yet these advances do not eliminate the need for individualized judgment.
Disability does not determine reproductive potential.
Immigration history does not define health status.
A cancer diagnosis does not necessarily eliminate the possibility of future parenthood.
What matters is understanding the person, identifying meaningful medical considerations, and providing appropriate support.
Comprehensive preconception care should not require every patient to fit the same model of health. It should adapt to the individual's circumstances while preserving dignity, autonomy, and access to evidence-informed healthcare.
We believe the future of reproductive wellness should be more comprehensive, collaborative, and fundamentally human.
Because preparing for pregnancy is not about meeting one standardized definition of health.
It is about helping individuals pursue informed reproductive goals within the realities of their own lives.
Research References
Ruhl C, Moran B. The clinical content of preconception care: preconception care for special populations. American Journal of Obstetrics & Gynecology. 2008;199(6 Suppl 2)–S388. https://doi.org/10.1016/j.ajog.2008.09.019
Dev A, Horner-Johnson W, Schaefer A, et al. Identifying pregnant women with disabilities and maternal and newborn outcomes. JAMA Network Open. 2025;8(3). https://doi.org/10.1001/jamanetworkopen.2025.2159
Health and Health Care Access Among Afghan Refugee Women in the United States. JAMA Network Open. 2026. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2852535
Su HI, Lacchetti C, Letourneau J, et al. Fertility preservation in people with cancer: ASCO guideline update. Journal of Clinical Oncology. 2025;43:1488–1515. https://doi.org/10.1200/JCO-24-02782
Partridge AH, Niman SM, Ruggeri M, et al. Interrupting endocrine therapy to attempt pregnancy after breast cancer. New England Journal of Medicine. 2023;388:1645–1656. https://doi.org/10.1056/NEJMoa2212856
De Backer J, Haugaa KH, et al. 2025 ESC Guidelines for the management of cardiovascular disease and pregnancy. European Heart Journal. 2025;46:4462–4567. https://doi.org/10.1093/eurheartj/ehaf193
Cardiovascular care in adult cancer survivorship post-therapy: a cross-sectional analysis of clinical practice guidelines. Cardio-Oncology. 2026. https://doi.org/10.1186/s40959-026-00493-z
American Society for Reproductive Medicine. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. https://www.asrm.org/practice-guidance/
Children's Oncology Group. Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers. https://www.survivorshipguidelines.org/
Centers for Disease Control and Prevention. Immigrant and Refugee Health. https://www.cdc.gov/immigrant-refugee-health/
American College of Obstetricians and Gynecologists. Access to Obstetric and Gynecologic Care for Patients With Disabilities. https://www.acog.org/
National Cancer Institute. Fertility Issues in Girls and Women With Cancer. https://www.cancer.gov/about-cancer/treatment/side-effects/fertility-women
National Cancer Institute. Fertility Issues in Boys and Men With Cancer. https://www.cancer.gov/about-cancer/treatment/side-effects/fertility-men